Skip to main content

FDA issues warning on Latisse

The FDA recently issued a warning letter to Allergan, the makers of eyelash-lengthening medication Latisse, stating that the company “omitted and minimized” certain risks in their advertising. Specifically, the warning […]

Read More
Schedule a Consultation